Protalix BioTherapeutics PLX
NYSE PLX
$2.57 -0.07 (-2.65%)
As of: Oct 21, 2026 · 3:59 PM EDT

Protalix BioTherapeutics (PLX) Operating Margin (2010 - 2026)

Updated

Protalix BioTherapeutics' Operating Margin came in at 23.48% for Q2 2026, up 16.00 percentage points from 7.48% a year earlier but down 39.17 percentage points from the prior quarter.

Analysis

Protalix BioTherapeutics (PLX) Operating Margin (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Protalix BioTherapeutics reported Operating Margin of 28.89%, up 15.61 percentage points year-over-year; for FY2025, it came in at -10.43%, down 17.76 percentage points from FY2024.

  • Operating Margin carries a five-year change of -14.74 percentage points (FY2020 to FY2025).
  • Going back by year, Operating Margin was 7.34% in FY2024 (-8.64 pp), 15.97% in FY2023 (+43.29 pp), -27.32% in FY2022 (+26.04 pp) and -53.36% in FY2021 (-57.66 pp).
  • The five-year range for quarterly Operating Margin is -129.56% (Q1 2024) to 62.65% (Q1 2026).
  • Year-over-year, Operating Margin increased in six of the last eight quarters, with an average year-over-year change of +33.30 percentage points.
  • The fastest year-over-year change in Operating Margin over five years came in Q2 2023 (a gain of 121.33 percentage points), and the weakest in Q1 2024 (a drop of 103.92 percentage points).
  • Business Quant data shows PLX's Operating Margin at 62.65% (Q1 2026), -51.06% (Q4 2025) and 11.94% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Protalix BioTherapeutics 207.16 Mn 55.78 Mn 12.13 Mn 23.48%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.48%
Mar 31, 2026 62.65%
Dec 31, 2025 -51.06%
Sep 30, 2025 11.94%
Jun 30, 2025 7.48%
Mar 31, 2025 -40.99%
Dec 31, 2024 39.57%
Sep 30, 2024 22.22%
Jun 30, 2024 -18.01%
Mar 31, 2024 -129.56%
Dec 31, 2023 -53.55%
Sep 30, 2023 -18.24%
Jun 30, 2023 58.22%
Mar 31, 2023 -25.65%
Dec 31, 2022 -28.95%
Sep 30, 2022 -22.03%
Jun 30, 2022 -63.11%
Mar 31, 2022 -11.63%
Dec 31, 2021 -66.74%
Sep 30, 2021 -15.64%
API Access

Protalix BioTherapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=PLX&period=max&api_key=YOUR_API_KEY